CPC disruption by targeting either INCENP or Survivin, whose expression correlates with high-risk disease in primary tumours, causes apoptosis in neuroblastoma cells [[208], [209], [210]], although at least for Survivin, it is unclear whether this is attributable to its part played in glycolytic metabolism [42]. The gene discussed is BIRC5; the disease is neoplasm.